Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H5HJ
|
|||
| Former ID |
DPR000169
|
|||
| Drug Name |
ALN-PCS
|
|||
| Drug Type |
RNAi therapeutics
|
|||
| Indication | Hypercholesterolaemia [ICD-11: 5C80.0] | Preclinical | [1] | |
| Company |
Alnylam Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | PCSK9 messenger RNA (PCSK9 mRNA) | Target Info | . | [1] |
| WikiPathways | PCSK9-mediated LDLR degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc (2011). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.